Gwathmey, K.
176  results:
Search for persons X
?
2

D.1 Efficacy, safety, and tolerability of subcutaneous efga..:

Siddiqi, Z ; Allen, JA ; Basta, I...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  51 (2024)  s1 - p. S8-S9 , 2024
 
?
3

P.045 Safety profile overview of Efgartigimod Clinical Tria..:

Bril, V ; Behin, A ; Gwathmey, K...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  50 (2023)  s2 - p. S70-S70 , 2023
 
?
5

PB1334 Safety Profile of Efgartigimod from Clinical Trials ..:

Sholzberg, M. ; Gwathmey, K. ; Broome, C....
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101449 , 2023
 
?
6

SUN-001 A NEURO-RENAL SYNDROME WITH NEUROFASCIN ANTIBODIES:

BUKHARI, S. ; Cathro, H. ; Solorzano, G...
Kidney International Reports.  4 (2019)  7 - p. S152-S153 , 2019
 
?
8

Intracellular calcium and the relationship to contractility..:

Kim, C. S. ; Davidoff, A. J. ; Maki, T. M...
Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology.  170 (2000)  4 - p. 295-306 , 2000
 
?
9

Effects of pH and temperature on myocardial calcium-activat..:

Meadows, K. N. ; Hajjar, R. J. ; Gwathmey, J. K.
Journal of Comparative Physiology B: Biochemical, Systemic, and Environmental Physiology.  168 (1998)  7 - p. 526-532 , 1998
 
?
 
?
 
?
 
?
 
?
14

Mechanism of action of 2,3-butanedione monoxime on contract..:

Hajjar, R. J. ; Ingwall, J. S. ; Gwathmey, J. K.
American Journal of Physiology-Heart and Circulatory Physiology.  267 (1994)  1 - p. H100-H108 , 1994
 
1-15